BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8369526)

  • 1. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.
    Brooks SA; Leathem AJ; Camplejohn RS; Gregory W
    Breast Cancer Res Treat; 1993; 25(3):247-56. PubMed ID: 8369526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour.
    Brooks SA; Leathem AJ
    Lancet; 1991 Jul; 338(8759):71-4. PubMed ID: 1712062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
    O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
    Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
    Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
    Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between DNA ploidy and survival in patients with primary breast cancer.
    Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
    Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
    Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR
    Br J Cancer; 1995 Jan; 71(1):140-5. PubMed ID: 7819030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
    Toikkanen S; Joensuu H; Klemi P
    Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
    Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
    Oncology; 1996; 53(3):182-91. PubMed ID: 8643219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy and helix pomatia lectin binding as predictors of regional lymph node metastases and prognostic factors in breast cancer.
    Noguchi M; Thomas M; Kitagawa H; Kinishita K; Kinami S; Takamura H; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1993; 26(1):67-75. PubMed ID: 7691268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
    Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
    Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
    Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
    Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.